COMPANY
XIUSHI BIOPHARMA (NANTONG) CO LTD
XIUSHI BIOPHARMA (NANTONG) CO LTD: API manufacturer for Semaglutide, Tirzepatide, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Semaglutide | DMF 41460, type II, active, submitted 2025-03-12 Regulator FDA drug master file list |
|---|---|
| Tirzepatide | DMF 43983, type II, active, submitted 2026-03-30 Regulator FDA drug master file list |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.